Literature DB >> 12755844

The burden of illness of gastro-oesophageal reflux disease: impact on work productivity.

B B Dean1, J A Crawley, C M Schmitt, J Wong, J J Ofman.   

Abstract

BACKGROUND: The impact of gastro-oesophageal reflux disease on work productivity has become increasingly important, as the symptoms of gastro-oesophageal reflux disease affect individuals in their productive years of life. AIMS: To assess the impact of gastro-oesophageal reflux disease on reduced work productivity and to identify the predictors of reduced productivity.
METHODS: A sample of employed individuals reporting chronic heartburn was selected from US household mail survey respondents. Heartburn severity and frequency were recorded using a diary, and work productivity was assessed using the Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-oesophageal Reflux Disease. Predictors of reduced productivity were evaluated.
RESULTS: Over 30% of heartburn sufferers reported reduced productivity. Individuals with symptoms of gastro-oesophageal reflux disease (n = 1003) reported 6.0% reduced productivity attributable to symptoms. Over 48% of respondents with severe symptoms reported reduced productivity, compared with 40% and 12% of respondents with moderate and mild symptoms, respectively. Using logistic regression, severity, a younger age and nocturnal symptoms were associated with increased odds of reduced productivity. In those reporting nocturnal heartburn, medication use and sleep interference increased the odds of reduced productivity.
CONCLUSIONS: Reduced work productivity is seen in a large proportion of subjects on prescription medication for gastro-oesophageal reflux disease. Symptom severity and nocturnal heartburn are significantly associated with reduced work productivity, particularly when nocturnal heartburn interferes with sleep.

Entities:  

Mesh:

Year:  2003        PMID: 12755844     DOI: 10.1046/j.1365-2036.2003.01588.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  30 in total

1.  A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms.

Authors:  Edoardo G Giannini; Patrizia Zentilin; Pietro Dulbecco; Elena Iiritano; Claudio Bilardi; Edoardo Savarino; Carlo Mansi; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2006-09-15       Impact factor: 3.199

2.  Burden and cost of treatment for GERD.

Authors:  Yoshikazu Kinoshita; Shuichi Sato
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts.

Authors:  Samira Toghanian; Peter Wahlqvist; David A Johnson; Susan C Bolge; Bengt Liljas
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  Development of a frequent heartburn index.

Authors:  Donald E Stull; Patricia van Hanswijck de Jonge; Katherine Houghton; Christopher Kocun; David W Sandor
Journal:  Qual Life Res       Date:  2011-01-12       Impact factor: 4.147

6.  Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study.

Authors:  José Luis Calleja; M Bixquert; J Maldonado
Journal:  Dig Dis Sci       Date:  2006-07-29       Impact factor: 3.199

7.  The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study.

Authors:  John Birk; Ronald Pruitt; Gregory Haber; Isaac Raijman; Arthur Baluyut; Mick Meiselman; Shahriar Sedghi
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

Review 8.  A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective.

Authors:  Manishi Prasad; Peter Wahlqvist; Rich Shikiar; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications.

Authors:  Hye-Kyung Jung; Rok Seon Choung; Nicholas J Talley
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 10.  Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Kate McKeage; Stephanie K A Blick; Jamie D Croxtall; Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.